WSJ Minute Briefing - Sam Altman Has Explored Deal to Build a Rocket Company

Plus: A group of former FDA commissioners has criticized the agency’s new vaccine standards, citing risks to public health. And UBS says the world has more billionaires than ever. Daniel Bach hosts.


Sign up for WSJ’s free What’s News newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices